Granulosa Lutein Cells are a specialized type of cell that emerges during the transformation of a ruptured ovarian follicle into the corpus luteum, a temporary endocrine structure. These cells arise from the granulosa cells that surrounded the mature egg (oocyte) within the ovarian follicle. After ovulation, when the follicle ruptures and releases the egg, the remaining granulosa cells undergo changes to form granulosa lutein cells. These cells are crucial for the production of hormones, particularly progesterone, which is essential for preparing the uterine lining for potential embryo implantation during the menstrual cycle. Granulosa lutein cells respond to luteinizing hormone (LH) and human chorionic gonadotropin (hCG), regulating their function. They produce progesterone, creating an environment conducive to early pregnancy. If fertilization does not occur, the corpus luteum regresses, leading to a drop in progesterone levels and the initiation of the menstrual phase. Understanding the physiology of granulosa lutein cells is crucial in the context of reproductive health and fertility. Dysregulation or dysfunction of these cells can contribute to conditions such as luteal phase defects and infertility. Research on the molecular and hormonal mechanisms governing granulosa lutein cells provides valuable insights into reproductive processes and informs clinical approaches in assisted reproductive technologies and fertility treatments. The dynamic interplay of granulosa lutein cells within the intricate hormonal milieu highlights their pivotal role in female reproductive function.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States